Results 121 to 130 of about 5,352 (210)

Validation of a LC-MS/MS Assay for Rapid and Simultaneous Quantification of Cobicistat and Venetoclax in Human Plasma and Serum. [PDF]

Biomed Chromatogr
Westra N, van Hateren K, Kosterink JGW, Lub-de Hooge MN, Oude Munnink TH, Touw DJ.   +5 more
europepmc   +1 more source

Renal and Cardiovascular Complications Following Type 2 Diabetes Mellitus in People With and Without HIV: Data From the Cohort Study on Morbidity and HIV in Sweden (COSMOHS) Between 2010 and 2024. [PDF]

Clin Infect Dis
Killander Möller I, Wagner P, Brännström J, Bäckdahl T, Elvstam O, Gisslén M, Hedberg P, Mellgren Å, Månsson F, Nauclér P, Nilsson J, Nowak P, Sparén P, Eliasson B, Carlander C.   +14 more
europepmc   +1 more source

Osimertinib Cost Minimization in Non-Small Cell Lung Cancer (NSCLC) Treatment: Hypothesis Generation for a Population Pharmacokinetic Approach for Equivalent Dose Optimization of Osimertinib in Combination with Cobicistat. [PDF]

J Clin Pharmacol
Westra N, Kruithof PD, Croes S, van Geel RMJM, Hendriks LEL, Touw DJ, Kosterink JGW, Stevens J, Oude Munnink TH, Mian P.   +9 more
europepmc   +1 more source

Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]

Front Pharmacol
Spanakis M, Alexakis K, Ioannou P.
europepmc   +1 more source

Contemporary Single and Multi-Tablet HIV Treatment Regimens Are Associated With Similar Levels of Viral Suppression. [PDF]

Open Forum Infect Dis
Yao K, Lawson L, Pistoresi R, Sullivan D, Golden MR.   +4 more
europepmc   +1 more source

Changing renal profile and early eGFR dynamics after ART initiation or switch in a large Italian HIV cohort. [PDF]

Front Med (Lausanne)
Maggi P, Ceccarelli M, Ricci ED, Orofino G, Menzaghi B, Squillace N, Taramasso L, De Socio GV, Piconi S, Madeddu G, Pellicanò GF, Lagi F, Di Biagio A, Bonfanti P.   +13 more
europepmc   +1 more source

Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]

BMJ Open
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc   +1 more source

Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]

BMC Infect Dis
O'Rourke J, Townsend CL, Milanzi E, Castro H, Collins IJ, Judd A, Jesson J, Leroy V, Penazzato M, Vicari M, Renaud F.   +10 more
europepmc   +1 more source

Which drugs will Medicare negotiate next? Predicting selected drugs for Initial Price Applicability Year 2029. [PDF]

J Manag Care Spec Pharm
Li KH, Cousin EM, Sullivan SD.
europepmc   +1 more source